Description
Product Overview
BPC & TB Blend combines BPC-157 and TB-500 in a single lyophilised research preparation, with 5mg of each peptide supplied for a total peptide content of 10mg.
BPC-157 and TB-500 are investigated in different but overlapping areas of peptide and cellular biology. BPC-157 is commonly studied in models involving cellular migration, adhesion and signalling, while TB-500-related research is associated with actin-linked cytoskeletal processes and cellular movement.
Supplying both peptides together provides researchers with a convenient dual-component material for controlled studies examining interactions between these pathways.
Product Specification
Product: BPC & TB Blend
BPC-157 content: 5mg
TB-500 content: 5mg
Total peptide content: 10mg
Form: Lyophilised peptide blend
Minimum purity standard: ≥98%
Batch traceability: Maintained
SKU: PB-BPCTB-10
Quality, Testing & Traceability
Pronoia maintains batch traceability for BPC & TB Blend and retains supporting documentation for the supplied research material.
The supplied peptide material is subject to analytical verification, with batch-specific results used to confirm identity, purity and consistency in accordance with the applicable supplier documentation.
Where a particular analytical method or result is stated for an individual batch, the corresponding Certificate of Analysis should be treated as the authoritative reference.
Certificate of Analysis (COA) and Safety Data Sheet (SDS) documentation are available to support laboratory records and material assessment.
Research Context
BPC-157 and TB-500 are investigated within laboratory models examining different aspects of cellular signalling and structural biology.
Research areas associated with these peptides include:
- Cellular migration and motility mechanisms
- Cell adhesion and signalling pathways
- Actin-associated cytoskeletal organisation
- Angiogenic and endothelial signalling models
- Extracellular-matrix and structural tissue research
- Interactions between complementary peptide signalling pathways
BPC-157 has been investigated in experimental models involving fibroblast migration and cellular adhesion signalling. Thymosin-beta-related research has explored actin binding, cytoskeletal regulation and cellular movement.
The combined formulation therefore provides a practical research material for studies where both peptide systems are being examined within the same controlled experimental design.
Storage & Handling
BPC & TB Blend is supplied in lyophilised form to support stability during storage and laboratory handling.
The product should be stored under the temperature-controlled conditions specified by Pronoia and the applicable batch documentation, protected from unnecessary heat, moisture and repeated environmental exposure.
Researchers should follow appropriate laboratory procedures when preparing or handling the material and use validated protocols appropriate to their individual experimental requirements.
Batch-specific storage information should take precedence where supplied.
Delivery & Documentation
BPC & TB Blend is supplied through Pronoia’s tracked UK delivery service using its established research-product fulfilment process.
Batch traceability is maintained and Certificate of Analysis (COA) and Safety Data Sheet (SDS) documentation are available to support laboratory records and material assessment.
Current dispatch availability and applicable delivery conditions are displayed directly on the product page and remain subject to Pronoia’s delivery terms.
Research Use Statement
BPC & TB Blend supplied by Pronoia Bio is intended strictly for controlled laboratory research and experimental use.
It is not supplied for human or veterinary use and should not be treated as a medicine or consumer healthcare product.
Purchasers are responsible for ensuring that the material is used appropriately within their research environment and in accordance with applicable requirements.
